Scheduled maintenance will begin on May 30th, 2025. Server will be temporarily unavailable — learn more.
current user: public

If you have questions about the server, please let us know.

Query: PB017124 _Gut.Meta.Jp.0039711_ gi|162659581|dbj|BAAX01000024.1||2 (+ 385:1498~0 complete), from HGM_OVER

Results of FFAS03 search in NEW_HUMAN_DOMAINS
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .
# Score Template Links and tools%idFirst ASAQAKQTVKVLEYCPAPGQFTNKLPEINNTMSAEERLKACEEQLEDGNLVCLGAAGGYITVALDQPIKNGKGSDIRILGNAFYSANDPKYGDATIGGSVEPGIVYVGVGSSPETAEWYELAGSEYYTTEMHRFEITYYKPTVETGEIKTPYITIDNYIRWTASWTNPDGSKQTAEGWQPKNVYHKQSYWPAWEENDQITFRGARLPDNAVNYGGDGSDPDNPQYWVSYRYAADSYGYADAAPNSDNVYTTFDLDWAVDSDGNPKHLDHADFIRIQSGVLQQCGWTGETSTEVGRITNLast
1 -6.380sp|A6NHS7|MANS4_HUMAN MANSC domain-containing protein 4 OS=Homo sapiens GN=MANSC4 PE=4 SV=2  ali   17  1........................................................GTSAIL-YN--ITDGIDPDLLVFEQSPTYLNT.................................................................................................................................................................................................................. 29
2 -5.350sp|Q9UKA2|FBXL4_HUMAN F-box/LRR-repeat protein 4 OS=Homo sapiens GN=FBXL4 PE=1 SV=2  ali   1.....QYAKEVVDFSSHYGSENSMSYTMWNLAGVPNVFPSSGDFTQTAVFRTYGTWQDYVELTFEQQVY----TAVHVLET......................................................................................................................................................................................................................... 93
3 -5.190tr|B1AMT9|B1AMT9_HUMAN Uncharacterized protein (Fragment) OS=Homo sapiens GN=ZDHHC16 PE=4 SV=1  ali   23  50........................................................................................................................................................................................................................................................NSFGGSDTAVDAAFEPVYWLVDNVIR----------WFGVGRNDIATVS. 88
4 -5.190tr|E9PCL9|E9PCL9_HUMAN Uncharacterized protein OS=Homo sapiens GN=ZDHHC16 PE=4 SV=1  ali   23  50........................................................................................................................................................................................................................................................NSFGGSDTAVDAAFEPVYWLVDNVIR----------WFGVGRNDIATVS. 88
5 -5.070sp|Q7Z695|ADCK2_HUMAN Uncharacterized aarF domain-containing protein kinase 2 OS=Homo sapiens GN=ADCK2 PE=2 SV=1  ali   12  47.............................................................................................................................................................................................................................................................LLKATETSG-PT------YIKLGQWASTRRDLFSAFCAQFSKLHV 85
6 -4.600sp|Q8WXH0|SYNE2_HUMAN Nesprin-2 OS=Homo sapiens GN=SYNE2 PE=1 SV=3  ali   5............................................................................................................................................................................................................................................GMTESLLKALSPSDSLEIFTKLEEIQQQILQQKHSMILLENQIGCLTPELSELKKQYESVSD 66
7 -4.450tr|E7EV46|E7EV46_HUMAN Uncharacterized protein OS=Homo sapiens GN=ERCC6 PE=4 SV=1  ali   2......................................................................................................................................................................................................................................................RGPALLHID-AVEPSAQALELQGLG-VDVYDQDVLEQGVLQQVDNAIHEASR 56
8 -4.450sp|Q03468|ERCC6_HUMAN DNA excision repair protein ERCC-6 OS=Homo sapiens GN=ERCC6 PE=1 SV=1  ali   2......................................................................................................................................................................................................................................................RGPALLHID-AVEPSAQALELQGLG-VDVYDQDVLEQGVLQQVDNAIHEASR 56
9 -4.400tr|B4DW63|B4DW63_HUMAN Uncharacterized protein OS=Homo sapiens GN=NFYC PE=2 SV=1  ali   21  5.............................................................................................................................................................................................................................................................MQQIITNTGEPVQLNQLQYIRLAQPVSGTQVVQGQIQT....... 48
10 -4.400tr|F8W7L5|F8W7L5_HUMAN Uncharacterized protein OS=Homo sapiens GN=NFYC PE=4 SV=1  ali   21  5.............................................................................................................................................................................................................................................................MQQIITNTGEPVQLNQLQYIRLAQPVSGTQVVQGQIQT....... 48

FFAS is supported by the NIH grant R01-GM087218-01
1 4 8 0 6 7   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Pawlowski K, Pio F, Chu Z, Reed JC, Godzik A. PAAD - a new protein domain associated with apoptosis, cancer and autoimmune diseases. Trends Biochem Sci. 2001 Feb;26(2):85-7.